Pain complaints in patients with fibromyalgia versus chronic fatigue syndrome.
Bradley, L A, McKendree-Smith, N L, Alarcón, G S · Current review of pain · 2000 · DOI
Quick Summary
Both fibromyalgia (FM) and ME/CFS cause muscle and joint pain, but the underlying reasons differ between these conditions. People with FM alone have unusually sensitive pain responses to light touch or mild pressure (called allodynia), while people with ME/CFS do not typically show this. This study examined what brain and hormone system differences might explain why these two conditions cause pain in different ways.
Why It Matters
Understanding why FM and ME/CFS cause pain differently is crucial for developing targeted treatments and improving clinical diagnosis. Since these conditions are sometimes confused or occur together, clarifying their distinct pain mechanisms helps patients receive appropriate care and supports research into condition-specific interventions.
Observed Findings
Only fibromyalgia patients exhibit allodynia (abnormal pain sensitivity to mild stimulation), not ME/CFS patients
Both FM and CFS share certain neuroendocrine axis abnormalities
Central neuropeptide levels differ between FM and CFS
Functional brain activity patterns distinguish FM from CFS
Arthralgia and myalgia occur in both conditions despite different pain processing mechanisms
Inferred Conclusions
Shared neuroendocrine dysfunction may explain common symptoms (pain, fatigue) in both FM and CFS
Different central nervous system abnormalities (neuropeptides and brain activity) account for distinct pain characteristics between conditions
FM-specific allodynia likely reflects unique central sensitization mechanisms not present in ME/CFS
Remaining Questions
What specific neuropeptide abnormalities distinguish FM from ME/CFS, and how do they mechanistically drive different pain phenotypes?
Are the identified neuroendocrine and CNS differences stable over time or do they change with disease progression?
Can these biological markers be used clinically to reliably differentiate FM from ME/CFS or guide treatment selection?
What This Study Does Not Prove
This review does not prove causation—it identifies correlations between biological abnormalities and pain symptoms. The study does not establish whether these neuroendocrine and neuropeptide differences are primary causes or secondary consequences of the conditions. Additionally, findings from 2000 may not capture the full complexity of these disorders as understood by current research.